NASDAQ:TLPH Talphera (TLPH) Stock Price, News & Analysis $0.89 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.86▼$0.9050-Day Range$0.78▼$1.0852-Week Range$0.43▼$1.61Volume9,800 shsAverage Volume91,024 shsMarket Capitalization$15.05 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Get Talphera alerts: Email Address Talphera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside408.0% Upside$4.50 Price TargetShort InterestHealthy0.75% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.44Based on 2 Articles This WeekInsider TradingAcquiring Shares$5,411 Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($0.84) to ($1.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.87 out of 5 starsMedical Sector439th out of 936 stocksPharmaceutical Preparations Industry201st out of 436 stocks 3.5 Analyst's Opinion Consensus RatingTalphera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageTalphera has only been the subject of 2 research reports in the past 90 days.Read more about Talphera's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.75% of the float of Talphera has been sold short.Short Interest Ratio / Days to CoverTalphera has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talphera has recently decreased by 20.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalphera does not currently pay a dividend.Dividend GrowthTalphera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TLPH. Previous Next 3.0 News and Social Media Coverage News SentimentTalphera has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Talphera this week, compared to 8 articles on an average week.Search InterestOnly 7 people have searched for TLPH on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.MarketBeat Follows3 people have added Talphera to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talphera insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,411.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 3.00% of the stock of Talphera is held by insiders.Percentage Held by InstitutionsOnly 37.67% of the stock of Talphera is held by institutions.Read more about Talphera's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Talphera are expected to decrease in the coming year, from ($0.84) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talphera is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talphera is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalphera has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Talphera's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About Talphera Stock (NASDAQ:TLPH)Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.Read More TLPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TLPH Stock News HeadlinesMay 20, 2024 | prnewswire.comTalphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 17, 2024 | msn.comTalphera, Inc. (NASDAQ:TLPH) Q1 2024 Earnings Call TranscriptJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.May 16, 2024 | markets.businessinsider.comOptimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment DelayMay 16, 2024 | prnewswire.comTalphera to Participate at A.G.P. Virtual Healthcare ConferenceMay 15, 2024 | finance.yahoo.comTalphera Inc (TLPH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...May 14, 2024 | investorplace.comTLPH Stock Earnings: Talphera Beats EPS for Q1 2024May 14, 2024 | prnewswire.comTalphera Announces First Quarter 2024 Financial Results and Provides Corporate UpdateJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.May 13, 2024 | msn.comAcelRx Pharmaceuticals Q1 2024 Earnings PreviewMay 6, 2024 | msn.comMaxim Group Initiates Coverage of Talphera (TLPH) with Buy RecommendationMay 2, 2024 | prnewswire.comTalphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024April 25, 2024 | finance.yahoo.comTalphera, Inc. (TLPH)April 13, 2024 | finance.yahoo.comTalphera, Inc. (TLPH) Stock Historical Prices & Data - Yahoo FinanceMarch 21, 2024 | msn.com5 years after it was yanked off stores, GOG's bringing underrated spy RPG Alpha Protocol in from the cold with fewer crashes and new achievementsMarch 20, 2024 | msn.comAlpha Protocol Finally Available Again Five Years After Being DelistedMarch 20, 2024 | seekingalpha.comTaysha: Initial Rett Syndrome Data Leads To Other 2024 CatalystsMarch 20, 2024 | msn.comCult classic spy RPG Alpha Protocol is back on PC after being delisted in 2019See More Headlines Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/27/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TLPH Previous SymbolNASDAQ:TLPH CUSIPN/A CIK1427925 Webtalphera.com Phone650-216-3500Fax650-216-6500Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+408.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,400,000.00 Net MarginsN/A Pretax Margin-2,197.39% Return on Equity-96.30% Return on Assets-63.20% Debt Debt-to-Equity RatioN/A Current Ratio5.97 Quick Ratio5.97 Sales & Book Value Annual Sales$650,000.00 Price / Sales23.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book1.07Miscellaneous Outstanding Shares16,990,000Free Float16,483,000Market Cap$15.05 million OptionableOptionable Beta0.34 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Vincent J. Angotti (Age 56)CEO & Director Comp: $906.54kDr. Pamela Pierce Palmer M.D. (Age 61)Ph.D., Co-Founder & Chief Medical Officer Comp: $699.75kMr. Raffi Mark Asadorian (Age 55)Chief Financial Officer Comp: $637.5kMr. Anil N. Dasu (Age 61)Chief Engineering Officer Comp: $478.09kKey CompetitorsMural OncologyNASDAQ:MURAImmix BiopharmaNASDAQ:IMMXRockwell MedicalNASDAQ:RMTIAnebulo PharmaceuticalsNASDAQ:ANEBHillstream BioPharmaNASDAQ:HILSView All CompetitorsInsidersVincent J AngottiBought 1,304 shares on 6/14/2024Total: $1,408.32 ($1.08/share)Vincent J AngottiBought 4,126 shares on 6/12/2024Total: $4,002.22 ($0.97/share)View All Insider Transactions TLPH Stock Analysis - Frequently Asked Questions How have TLPH shares performed this year? Talphera's stock was trading at $0.7989 at the beginning of 2024. Since then, TLPH shares have increased by 10.9% and is now trading at $0.8858. View the best growth stocks for 2024 here. How were Talphera's earnings last quarter? Talphera, Inc. (NASDAQ:TLPH) posted its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.28) by $0.12. How do I buy shares of Talphera? Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TLPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
